The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
D-dimers as a tumor marker in GIST: Can it reduce the frequency of CT scanning in patients receiving palliative imatinib?
Jenny F. Seligmann
No relevant relationships to disclose
Peter Hall
No relevant relationships to disclose
Patrick Hamilton
No relevant relationships to disclose
Simon Richard Lord
No relevant relationships to disclose
Paul Baxter
No relevant relationships to disclose
Maria Marples
No relevant relationships to disclose
Daniel P. Stark
No relevant relationships to disclose